Evidence map›Paper›PMID 39682845›Full record

ArticleFoods (Basel, Switzerland)2024

Hepatoprotective, Lipid-Lowering and Antioxidant Effects of Mangaba Powder (

Bernadete de Lourdes de Araújo Silva, Margarida Angélica da Silva Vasconcelos, Kamila Sabino Batista, Marcos dos Santos Lima, Fabiane Rabelo da Costa Batista, Hassler Clementino Cavalcante, Lydiane de Lima Tavares Toscano, Alexandre Sérgio Silva, Aline Barbosa D'Oliveira, Adriano Francisco Alves and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Bernadete de Lourdes de Araújo SilvaNutrition Department, Universidade Federal de Pernambuco, Recife 50670-901, Brazil.
Margarida Angélica da Silva VasconcelosNutrition Department, Universidade Federal de Pernambuco, Recife 50670-901, Brazil.
Kamila Sabino BatistaExperimental Nutrition Laboratory, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0001-5766-8595
Marcos dos Santos LimaDepartment of Food Technology, Federal Institute of the Sertão of Pernambuco (IFSertãoPE), Petrolina 56316-686, Brazil;ORCID 0000-0001-7057-4868
Fabiane Rabelo da Costa BatistaInstituto Nacional do Semiárido, Campina Grande 58434-700, Brazil.ORCID 0000-0003-3868-1131
Hassler Clementino CavalcanteNutrition Department, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0002-6817-0423
Lydiane de Lima Tavares ToscanoNutrition Department, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0003-0020-6220
Alexandre Sérgio SilvaNutrition Department, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.
Aline Barbosa D'OliveiraExperimental Nutrition Laboratory, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.
Adriano Francisco AlvesDepartment of Physiology and Pathology, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.
Jailane de Souza AquinoNutrition Department, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0002-7221-9867

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the potential effects of administering mangaba powder on liver function and somatic, oxidative and lipid metabolism parameters in rats fed a high-fat diet. Prepared mangaba powder has important amounts of phenolic compounds, vitamin C, dietary fiber and oligosaccharides. A total of 32 adult Wistar rats were initially randomized into two groups for the biological assay: normal-fat (NF, n = 16) and high-fat (HF, n = 16) diets for 21 days. These rats were subsequently subdivided into four groups: NF (n = 8), HF (n = 8), normal-fat diet with mangaba powder administration (NFMG, n = 8) and high-fat diet with mangaba powder administration (HFMG, n = 8). The treatment with mangaba powder (400 mg/kg) lasted an additional 28 days. Compared to the HF rats, the HFMG rats showed an 8% reduction in the body mass index. Treatment with mangaba reduced the serum cholesterol by 18%, as well as the hepatic deposition of triacylglycerides by 26% and cholesterol by 25%, in addition to increasing bile acid synthesis by 77% in this organ. Mangaba powder consumption attenuated the degree of hepatic steatosis, reduced lipid peroxidation and increased the serum and hepatic antioxidant capacity in HFMG rats. These results show that the consumption of mangaba powder had lipid-lowering, hepatoprotective and antioxidant effects, especially in HFMG rats, which may be associated with an additive and synergistic action between the bioactive compounds present in the product.

Indexed as

antioxidantsApocynaceae familydehydrated fruitsdyslipidemiahyperlipidic diet

Identifiers

PMID39682845
PMCPMC11640672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.